logo
Verified
High Ratings
70+ Specializations
200+ Therapies
Research Phase I/II/III

About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Italy Poland +1
  • Study Comparing Dostarlimab and Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Germany Italy Poland Romania Spain
  • Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Austria Czechia France Germany Italy The Netherlands +3
  • Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1 1
    Czechia France Hungary Poland Spain
  • Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Bulgaria Denmark France Germany Italy +6
  • Study on the Safety and Tolerability of BMS-986435 in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

    Not recruiting

    2 1 1
    Investigated drugs:
    Italy Poland Spain
  • Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers

    Not recruiting

    1 1 1 1 1
    Poland Spain
  • Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Austria Belgium France Germany Greece Hungary +6
  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Germany +9